GLP-1 Receptor Agonists and Neurodegenerative Diseases in 2025 GLP-1 receptor agonists like semaglutide (Ozempic®) are typically given via a weekly injection pen. Originally developed for diabetes and obesity, these drugs are now being studied for their effects on the brain. From Diabetes to Dementia: Why GLP-1 Drugs Are Being Tested for Brain Diseases Just a…
Read more
